ClinicalTrials.gov
public full text
Public Domain
Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone
Purpose: To study the etiology and the epigenetic pathways leading to and regulating chronic itch. Similarly, to examine the mechanisms underlying skin changes, including epigenetic alterations while also testing the efficacy of opioid antagonists in atopic dermatitis. In this study, the investigators aim to examine chronic sensory disorder mechanisms related to chronic itch.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone#849581
- Atopic Dermatitis (AD) and Food Allergy#834061
- Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis#1101990
- Impact of COVID-19 on Occupational Dermato-allergology Consultations of Health Peronnel#1196549
- Evaluation of Post Burn Rehabilitation Population for Itch Control#1365156
Record · ID 1445791
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive